Madison Avenue Partners LP's Q2 2024 13F: 6 new positions, 4 exits
Form 13F-HR for the quarter ended Jun 30, 2024 · filed Aug 14, 2024 · 20 reported positions · accession 0001801265-24-000009
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| New | SOLVENTUM CORP (SOLV) | — | 16.5% | +16.5 pts | +2.46M sh | new |
| Reduced | SHARKNINJA INC (SN) | 18.2% | 6.9% | −11.3 pts | −1.09M sh | −60% |
| Exited | HESS CORP (HES) | 7.4% | — | −7.4 pts | −300K sh | −100% |
| New | QUIDELORTHO CORP (QDEL) | — | 6.3% | +6.3 pts | +1.5M sh | new |
| Increased | GLOBUS MED INC (GMED) | 6.1% | 12.3% | +6.2 pts | +713K sh | +101% |
| New | DUCOMMUN INC DEL (DCO) | — | 2.8% | +2.8 pts | +382K sh | new |
| Increased | GRAHAM HLDGS CO (GHC) | 26.1% | 20.6% | −5.5 pts | +22,767 sh | +11% |
| Increased | THERAVANCE BIOPHARMA INC (TBPH) | 10.1% | 9.1% | −1.0 pts | +1.5M sh | +21% |
| New | NEWS CORP NEW (NWSA) | — | 1.5% | +1.5 pts | +428K sh | new |
| Exited | ORION GROUP HLDGS INC (ONL) | 1.5% | — | −1.5 pts | −2.62M sh | −100% |
| Increased | WILEY JOHN & SONS INC (WLYB) | 8.4% | 8.4% | 0.0 pts | +264K sh | +19% |
| Increased | ATMUS FILTRATION TECHNOLOGIES INC (ATMU) | 0.4% | 1.5% | +1.1 pts | +339K sh | +441% |
| Reduced | HOMESTREET INC (HMST) | 2.2% | 0.3% | −1.9 pts | −664K sh | −73% |
| Exited | MERRIMACK PHARMACEUTICALS INC (MACK) | 0.9% | — | −0.9 pts | −387K sh | −100% |
| Exited | GOSSAMER BIO INC (GOSS) | 0.8% | — | −0.8 pts | −4.14M sh | −100% |
| New | ZIMVIE INC (ZIMV) | — | 0.6% | +0.6 pts | +271K sh | new |
| New | NEWS CORP NEW (NWS) | — | 0.2% | +0.2 pts | +52,534 sh | new |
| Increased | INDIVIOR PLC (INDV) | 0.6% | 0.5% | −0.1 pts | +60,537 sh | +37% |
| Reduced | CENTRAL & EASTERN EUROPE FD (CEE) | 0.6% | 0.5% | −0.2 pts | −85,777 sh | −20% |
| Increased | 2SEVENTY BIO INC (TSVT) | 2.1% | 1.2% | −0.9 pts | +130K sh | +5% |
| Increased | OVID THERAPEUTICS INC (OVID) | 1.8% | 0.4% | −1.4 pts | +434K sh | +12% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 92.7% of the equity book
Changes in the top 10 this quarter: SOLV entered · QDEL entered · DCO entered · HES left · HMST left · TSVT left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | GRAHAM HLDGS CO (GHC) | 26.1% | 20.6% | |
| 2 | SOLVENTUM CORP (SOLV) | 0.0% | 16.5% | Entered the top 10 |
| 3 | GLOBUS MED INC (GMED) | 6.1% | 12.3% | |
| 4 | THERAVANCE BIOPHARMA INC (TBPH) | 10.1% | 9.1% | |
| 5 | WILEY JOHN & SONS INC (WLYB) | 8.4% | 8.4% | |
| 6 | SHARKNINJA INC (SN) | 18.2% | 6.9% | |
| 7 | QUIDELORTHO CORP (QDEL) | 0.0% | 6.3% | Entered the top 10 |
| 8 | STAGWELL INC (STGW) | 7.2% | 6.2% | |
| 9 | NELNET INC (NNI) | 4.4% | 3.7% | |
| 10 | DUCOMMUN INC DEL (DCO) | 0.0% | 2.8% | Entered the top 10 |
| — | HESS CORP (HES) | 7.4% | 0.0% | Left the top 10 |
| — | HOMESTREET INC (HMST) | 2.2% | 0.3% | Left the top 10 |
| — | 2SEVENTY BIO INC (TSVT) | 2.1% | 1.2% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).